RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 76 filers reported holding RA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $179,000 | +179.7% | 8,000 | +128.6% | 0.00% | – |
| Q4 2018 | $64,000 | -74.7% | 3,500 | -75.0% | 0.00% | -100.0% |
| Q3 2018 | $253,000 | +82.0% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $139,000 | +87.8% | 14,000 | 0.0% | 0.00% | – |
| Q1 2018 | $74,000 | -49.0% | 14,000 | -17.6% | 0.00% | -100.0% |
| Q4 2017 | $145,000 | -66.9% | 17,000 | -43.3% | 0.00% | -50.0% |
| Q3 2017 | $438,000 | -29.1% | 30,000 | -9.1% | 0.00% | -33.3% |
| Q2 2017 | $618,000 | +61.4% | 33,000 | +83.3% | 0.00% | +50.0% |
| Q1 2017 | $383,000 | +71.7% | 18,000 | +22.8% | 0.00% | +100.0% |
| Q4 2016 | $223,000 | – | 14,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |